Highlights
MWC network plays key role in national response to COVID-19 pandemic
Investigators from across the Centre have been instrumental in developing the tools necessary to track and trace the virus, i...
read the full story
New Otago biotech startup targets cancer
Amaroq Therapeutics, a new biotech startup company with the goal of developing targeted drugs for cancer, has been awarded si...
read the full story
Exciting building blocks unlock peptide potential
Coined ‘bacterial super villains’, the World Health Organisation has a list of ‘priority pathogens’ which have developed resi...
read the full story
MWC teacher workshops focus on COVID-19
In 2020/21 the Centre adapted its teacher professional development programme to increase understanding around the COVID-19 pa...
read the full story
Pilin protein may combat the hairy problem of human pathogens
MWC investigations into the puzzle of a nanoscopic skyscraper – ‘the pilus’ – have sparked separate lines of research into no...
read the full story
Dual approach drives precision medicine
Two pioneering studies by MWC investigators are looking at the resilience and risk factors for type 2 diabetes in Māori and P...
read the full story
Chasing a cancer suspect to cytokinesis
A potential new way to target aggressive cancers has been identified through a MWC project as part of the research programme ...
read the full story
Collaboration a bridge to new knowledge
Four years ago, MWC and The Moko Foundation formed the Waharoa ki te Toi Health Research Centre in Kaitaia to drive outreach ...
read the full story
A bountiful career of exceptional science
MWC founding Principal Investigator, Professor Bill Denny, was recognised this year with New Zealand’s highest honour.
read the full story